Genetic epidemiology and nonsyndromic structural birth defects from candidate genes to epigenetics

JAMA Pediatrics

Volumn 168, Issue 4, 2014, Pages 371-377

  Hobbs, Charlotte A ^a   Chowdhury, Shimul ^a   Cleves, Mario A ^a   Erickson, Stephen ^a   MacLeod, Stewart L ^a   Shaw, Gary M S ^b   Shete, Sanjay ^c   Witte, John S ^d   Tycko, Benjamin ^e  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e Department of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIRTH DEFECT; EPIGENETICS; GENE FREQUENCY; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC EPIDEMIOLOGY; GENOME; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; PRIORITY JOURNAL; REVIEW; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

CONGENITAL ABNORMALITIES; EPIGENESIS, GENETIC; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MOLECULAR EPIDEMIOLOGY;

EID: 84898431456     PISSN: 21686203     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamapediatrics.2013.4858     Document Type: Review

References (75)

1. Hobbs CA, Cleves MA, Simmons CJ. Genetic epidemiology and congenital malformations: from the chromosome to the crib [published correction appears in Arch Pediatr Adolesc Med. 2002;156(10):1051]. Arch Pediatr Adolesc Med. 2002;156(4):315-320.
2. Christianson A, Howson CP, Modell B. March of Dimes Global Report on Birth Defects: The Hidden Toll of Dying and Disabled children. White Plains, NY: March of Dimes Foundation; 2006.
3. Autism and Developmental Disabilities Monitoring Network Surveillance Year 2008 Principal Investigators; Centers for Disease Control and Prevention. Prevalence of autism spectrum disorders-Autism and Developmental Disabilities Monitoring Network, 14 sites, United States, 2008. MMWR Surveill Summ. 2012;61(3):1-19.
4. Department of Health and Human Services; Centers for Disease Control and Prevention; National Cancer Institute. 1999-2005 United States Cancer Statistics (USCS): Incidence and Mortality Web-Based Report. Atlanta, GA: Centers for Disease Control and Prevention; 2009.
5. Liese AD, D'Agostino RB Jr, Hamman RF, et al; SEARCH for Diabetes in Youth Study Group. The burden of diabetes mellitus among US youth: prevalence estimates from the SEARCH for Diabetes in Youth Study. Pediatrics. 2006;118(4):1510-1518.
6. Parker SE, Mai CT, Canfield MA, et al; National Birth Defects Prevention Network. Updated National Birth Prevalence estimates for selected birth defects in the United States, 2004-2006. Birth Defects Res A Clin Mol Teratol. 2010;88(12):1008-1016.
7. Hobbs CA, ClevesMA, Melnyk S, ZhaoW, James SJ. Congenital heart defects and abnormal maternal biomarkers of methionine and homocysteine metabolism. Am J Clin Nutr. 2005;81(1):147-153.
8. Friedman JM. Using genomics for birth defects epidemiology: can epigenetics cut the GxE Gordian knot? Birth Defects Res A Clin Mol Teratol. 2011;91(12):986-989.
9. Waddington CH. Organisers and Genes. Cambridge, England: Cambridge University Press; 1940.
10. Srivastava D. Genetic regulation of cardiogenesis and congenital heart disease. Annu Rev Pathol. 2006;1:199-213.
11. Itikala PR, Watkins ML, Mulinare J, Moore CA, Liu Y. Maternal multivitamin use and orofacial clefts in offspring. Teratology. 2001;63(2):79-86.
12. van Beynum IM, den HeijerM, Blom HJ, Kapusta L. The MTHFR 677C->T polymorphism and the risk of congenital heart defects: a literature review and meta-analysis. QJM. 2007;100(12): 743-753.
13. Botto LD, Mulinare J, Erickson JD. Occurrence of congenital heart defects in relation to maternal multivitamin use. Am J Epidemiol. 2000;151(9):878-884.
14. Shaw GM, LuW, Zhu H, et al. 118 SNPs of folate-related genes and risks of spina bifida and conotruncal heart defects. BMC Med Genet. 2009;10:49.
15. Pan Y, ZhangW,Ma J, et al. Infants' MTHFR polymorphisms and nonsyndromic orofacial clefts susceptibility: ameta-analysis based on 17 case-control studies. Am J Med Genet A. 2012;158A(9):2162-2169.
16. Yin M, Dong L, Zheng J, Zhang H, Liu J, Xu Z. Meta analysis of the association between MTHFR C677T polymorphism and the risk of congenital heart defects. Ann Hum Genet. 2012;76(1):9-16.
17. Hinds DA, Stuve LL, Nilsen GB, et al. Whole-genome patterns of common DNA variation in three human populations. Science. 2005;307(5712):1072-1079.
18. Kruglyak L, Nickerson DA. Variation is the spice of life. Nat Genet. 2001;27(3):234-236.
19. International HapMap Consortium. The International HapMap Project. Nature. 2003;426(6968):789-796.
20. Couzin J. Genomics: consensus emerges on HapMap strategy. Science. 2004;304(5671): 671-673.
21. Leslie EJ, Murray JC. Evaluating rare coding variants as contributing causes to non-syndromic cleft lip and palate. Clin Genet. 2013;84(5): 496-500.
22. Greene ND, Stanier P, Copp AJ. Genetics of human neural tube defects. Hum Mol Genet. 2009;18(R2):R113-R129.
23. Gelb B, Brueckner M, ChungW, et al; Pediatric Cardiac Genomics Consortium. The Congenital Heart Disease Genetic Network Study: rationale, design, and early results. Circ Res. 2013;112(4):698-706.
24. Dixon MJ, Marazita ML, Beaty TH, Murray JC. Cleft lip and palate: understanding genetic and environmental influences. Nat Rev Genet. 2011;12(3):167-178.
25. Rana MS, Christoffels VM, Moorman AF. A molecular and genetic outline of cardiac morphogenesis. Acta Physiol (Oxf). 2013;207(4):588-615.
26. Tan WH, Gilmore EC, Baris HN. Human developmental genetics. In: Rimoin DL, Pyeritz RE, Korf BR, eds. Emery and Rimoin's Principles and Practice of Medical Genetics. 6th ed. Philadelphia, PA: Elsevier Science; 2013
27. Genome-wide association studies. National Human Genome Research Institute website. http://www.genome.gov/20019523. Accessed June 17, 2013.
28. Hunter DJ, Chanock SJ. Genome-wide association studies and "the art of the soluble". J Natl Cancer Inst. 2010;102(12):836-837.
29. van der Zanden LF, van Rooij IA, Feitz WF, et al. Common variants in DGKK are strongly associated with risk of hypospadias. Nat Genet. 2011;43(1):48-50.
30. Mangold E, Ludwig KU, Birnbaum S, et al. Genome-wide association study identifies two susceptibility loci for nonsyndromic cleft lip with or without cleft palate. Nat Genet. 2010;42(1):24-26.
31. Birnbaum S, Ludwig KU, Reutter H, et al. Key susceptibility locus for nonsyndromic cleft lip with or without cleft palate on chromosome 8q24. Nat Genet. 2009;41(4):473-477.
32. Beaty TH, Murray JC, Marazita ML, et al. A genome-wide association study of cleft lip with and without cleft palate identifies risk variants near MAFB and ABCA4 [published correction appears in Nat Genet. 2010;42(8):727]. Nat Genet. 2010;42(6):525-529.
33. Grant SF,Wang K, Zhang H, et al. A genome-wide association study identifies a locus for nonsyndromic cleft lip with or without cleft palate on 8q24. J Pediatr. 2009;155(6):909-913.
34. Hobbs CA, ClevesMA, Keith C, Ghaffar S, James SJ. NKX2.5 and congenital heart defects: a population-based study. Am J Med Genet A. 2005;134A(2):223-225.
35. Hobbs CA, James SJ, Parsian A, et al. Congenital heart defects and genetic variants in the methylenetetrahydroflate reductase gene. J Med Genet. 2006;43(2):162-166.
36. Olshan AF, Hobbs CA, Shaw GM. Discovery of genetic susceptibility factors for human birth defects: an opportunity for a National Agenda. Am J Med Genet A. 2011;155A(8):1794-1797.
37. Redon R, Ishikawa S, Fitch KR, et al. Global variation in copy number in the human genome. Nature. 2006;444(7118):444-454.
38. Greenway SC, Pereira AC, Lin JC, et al. De novo copy number variants identify new genes and loci in isolated sporadic tetralogy of Fallot. Nat Genet. 2009;41(8):931-935.
39. Warburton D, Ronemus M, Kline J, et al. The contribution of de novo and rare inherited copy number changes to congenital heart disease in an unselected sample of children with conotruncal defects or hypoplastic left heart disease. Hum Genet. 2014;133(1):11-27.
40. Bardakjian TM, Kwok S, Slavotinek AM, Schneider AS. Clinical report ofmicrophthalmia and optic nerve coloboma associated with a de novo microdeletion of chromosome 16p11.2. Am J Med Genet A. 2010;152A(12):3120-3123.
41. Srisupundit K, Brady PD, Devriendt K, et al. Targeted array comparative genomic hybridisation (array CGH) identifies genomic imbalances associated with isolated congenital diaphragmatic hernia (CDH). Prenat Diagn. 2010;30(12-13):1198-1206.
42. Shi M, Mostowska A, Jugessur A, et al. Identification ofmicrodeletions in candidate genes for cleft lip and/or palate. BirthDefects Res A Clin Mol Teratol. 2009;85(1):42-51.
43. Mefford HC, Shafer N, Antonacci F, et al. Copy number variation analysis in single-suture craniosynostosis: multiple rare variants including RUNX2 duplication in two cousins with metopic craniosynostosis. Am J Med Genet A. 2010;152A(9):2203-2210.
44. Weber S, Landwehr C, RenkertM, et al. Mapping candidate regions and genes for congenital anomalies of the kidneys and urinary tract (CAKUT) by array-based comparative genomic hybridization. Nephrol Dial Transplant. 2011;26(1):136-143.
45. Zhang F, GuW, HurlesME, Lupski JR. Copy number variation in human health, disease, and evolution. Annu Rev Genomics Hum Genet. 2009;10:451-481.
46. International Human Genome Sequencing Consortium. Finishing the euchromatic sequence of the human genome. Nature. 2004;431(7011): 931-945.
47. Metzker ML. Sequencing technologies-the next generation. Nat Rev Genet. 2010;11(1):31-46.
48. Korf BR, Rehm HL. New approaches to molecular diagnosis. JAMA. 2013;309(14):1511-1521.
49. Liu L, Li Y, Li S, et al. Comparison of next-generation sequencing systems. J Biomed Biotechnol. 2012;2012:251364.
50. Loman NJ,Misra RV, Dallman TJ, et al. Performance comparison of benchtop high-throughput sequencing platforms. Nat Biotechnol. 2012;30(5):434-439.
51. Vasta V, Merritt JL II, Saneto RP, Hahn SH. Next-generation sequencing formitochondrial diseases: a wide diagnostic spectrum. Pediatr Int. 2012;54(5):585-601.
52. Bamshad MJ, Ng SB, Bigham AW, et al. Exome sequencing as a tool for Mendelian disease gene discovery. Nat Rev Genet. 2011;12(11):745-755.
53. Manolio TA, Collins FS, Cox NJ, et al. Finding the missing heritability of complex diseases. Nature. 2009;461(7265):747-753.
54. Zaidi S, Choi M,Wakimoto H, et al. De novo mutations in histone-modifying genes in congenital heart disease. Nature. 2013;498(7453):220-223.
55. Thomas R, Sanna-Cherchi S,Warady BA, Furth SL, Kaskel FJ, Gharavi AG. HNF1B and PAX2 mutations are a common cause of renal hypodysplasia in the CKiD cohort. Pediatr Nephrol. 2011;26(6):897-903.
56. Gelb BD. Recent advances in understanding the genetics of congenital heart defects [published online August 29, 2013]. Curr Opin Pediatr. doi:10.1097/MOP.0b013e3283648826.
57. GeneTests. Bio-Reference Laboratories website. http://www.genetests.org. Accessed May 14, 2013.
58. RubinsteinWS,Maglott DR, Lee JM, et al. The NIH genetic testing registry: a new, centralized database of genetic tests to enable access to comprehensive information and improve transparency. Nucleic Acids Res. 2013;41(Database issue):D925-D935.
59. Green RC, Berg JS, GrodyWW, et al. American College of Medicine Genetics and Genomics: ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. https://www.acmg.net/docs/ACMG-eleases- ighly-Anticipated-ecommendations-n-ncidental-indings-n-linical-xome-nd-enome- equencing.pdf. Accessed January 10, 2014.
60. Schrijver I, Aziz N, Farkas DH, et al. Opportunities and challenges associated with clinical diagnostic genome sequencing: a report of the Association for Molecular Pathology. J Mol Diagn. 2012;14(6):525-540.
61. Norton N, Li D, Hershberger RE. Next-generation sequencing to identify genetic causes of cardiomyopathies. Curr Opin Cardiol. 2012;27(3):214-220.
62. Iossifov I, Ronemus M, Levy D, et al. De novo gene disruptions in children on the autistic spectrum. Neuron. 2012;74(2):285-299.
63. de Ligt J,Willemsen MH, van Bon BW, et al. Diagnostic exome sequencing in persons with severe intellectual disability. N Engl J Med. 2012;367(20):1921- 1929.
64. Weksberg R, Butcher DT, Grafodatskaya D, Choufani S, Tycko B. Epigenetics. In: Rimoin DL, Pyeritz RE, Korf BR, eds. Emery and Rimoin's Principles and Practice of Medical Genetics. 6th ed. Philadelphia, PA: Elsevier Sciences; 2013.
65. Berger SL, Kouzarides T, Shiekhattar R, Shilatifard A. An operational definition of epigenetics. Genes Dev. 2009;23(7):781-783.
66. Li E, Bestor TH, Jaenisch R. Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell. 1992;69(6):915-926.
67. Okano M, Bell DW, Haber DA, Li E. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell. 1999;99(3):247-257.
68. Pradhan S, Bacolla A,Wells RD, Roberts RJ. Recombinant human DNA (cytosine-5) methyltransferase: I, expression, purification, and comparison of de novo and maintenance methylation. J Biol Chem. 1999;274(46):33002-33010.
69. Wolff GL, Kodell RL, Moore SR, Cooney CA. Maternal epigenetics and methyl supplements affect agouti gene expression in Avy/a mice. FASEB J. 1998;12(11):949-957.
70. Cooney CA, Dave AA,Wolff GL. Maternal methyl supplements inmice affect epigenetic variation and DNA methylation of offspring. J Nutr. 2002;132(8 suppl):2393S-2400S.
71. Gonda TA, Kim YI, Salas MC, et al. Folic acid increases global DNA methylation and reduces inflammation to prevent Helicobacter-associated gastric cancer in mice. Gastroenterology. 2012;142(4):824-833.e7.
72. Frommer M, McDonald LE, Millar DS, et al. A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc Natl Acad Sci U S A. 1992;89(5):1827-1831.
73. Rakyan VK, Down TA, Balding DJ, Beck S. Epigenome-wide association studies for common human diseases. Nat Rev Genet. 2011;12(8): 529-541.
74. Maegawa S, Hinkal G, Kim HS, et al. Widespread and tissue specific age-related DNA methylation changes inmice. Genome Res. 2010;20(3):332-340.
75. Tycko B. Allele-specific DNA methylation: beyond imprinting. Hum Mol Genet. 2010;19(R2):R210-R220.